Acetyl-L-carnitine (ALCAR), the acetyl ester of carnitine, is regarded
as a compound of considerable interest because of its capacity to cou
nteract several physiological and pathological modifications typical o
f brain ageing processes. In particular, it has been demonstrated that
ALCAR can counteract the age-dependent reduction of several receptors
in the central nervous system of rodents, such as the NMDA receptoria
l system, the Nerve Growth Factor (NGF) receptors, those of glucocorti
coids, neurotransmitters and others, thereby enhancing the efficiency
of synaptic transmission, which is considerably slowed down by ageing.
The present review thus postulates the importance of ALCAR administra
tion in preserving and/or facilitating the functionality of carnitines
, the concentrations of which are diminished in the brain of old anima
ls.